KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Finished Goods (2016 - 2025)

CareDx (CDNA) has disclosed Finished Goods for 13 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 103.44% to $9.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, up 103.44% year-over-year, with the annual reading at $9.8 million for FY2025, 103.44% up from the prior year.
  • Finished Goods hit $9.8 million in Q4 2025 for CareDx, up from $9.5 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $9.8 million in Q4 2025 to a low of $2.4 million in Q1 2021.
  • Historically, Finished Goods has averaged $4.5 million across 5 years, with a median of $3.7 million in 2023.
  • Biggest YoY gain for Finished Goods was 129.79% in 2021; the steepest drop was 46.83% in 2021.
  • Year by year, Finished Goods stood at $3.9 million in 2021, then fell by 24.26% to $3.0 million in 2022, then grew by 23.5% to $3.7 million in 2023, then surged by 31.74% to $4.8 million in 2024, then skyrocketed by 103.44% to $9.8 million in 2025.
  • Business Quant data shows Finished Goods for CDNA at $9.8 million in Q4 2025, $9.5 million in Q3 2025, and $8.4 million in Q2 2025.